Effect of MA Regimen in Treatment of Adult Acute Non-lymphocytic Leukemia
Qingzhu Hu
Abstract
Qingzhu Hu
Abstract
Objective To evaluate mitoxantrone,cytarabine(MA) program for the induction treatment of adult acute non-lymphocytic leukemia(ANLL) patients with untreated patients.Methods Mitoxantrone an quinone(mitoxantrone) and cytosine arabinoside(cytarabine) in 35 cases of adult ANLL patients with chemotherapy.Results Clinical and hematological complete remission(CR) 15 cases(42.9%),partial remission(PR) 9 cases(25.7%),68.6% total efficiency.Conclusion On the basis of strong support for treatment,MA in the treatment of adults with refractory acute non-lymphocytic leukemia has a good effect,and its side effects can be tolerated.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate mitoxantrone,cytarabine(MA) program for the induction treatment of adult acute non-lymphocytic leukemia(ANLL) patients with untreated patients.Methods Mitoxantrone an quinone(mitoxantrone) and cytosine arabinoside(cytarabine) in 35 cases of adult ANLL patients with chemotherapy.Results Clinical and hematological complete remission(CR) 15 cases(42.9%),partial remission(PR) 9 cases(25.7%),68.6% total efficiency.Conclusion On the basis of strong support for treatment,MA in the treatment of adults with refractory acute non-lymphocytic leukemia has a good effect,and its side effects can be tolerated.
Key concepts: Mitoxantrone, Cytarabine, Medicine, Refractory (planetary science), Leukemia, Chemotherapy, Internal medicine, Regimen